Grant: Discovery Grants Program - Individual
Université de Montréal
$28,000.00
Molecular dissection studies of mammalian reovirus proteins using reverse genetics.
FY 2017-18
Summary
Mammalian reovirus has played an important role in our understanding of important biological mechanisms: virus entry, synthesis of nucleic acids and proteins, virus evolution, and more. In addition to its interest as a fundamental research tool, possible applications are now envisaged for this fascinating virus. In fact, some viruses, such as reovirus, could become our allies rather than just enemies to fight. Its ability to infect human beings, as well as a large number of animal species, without causing disease in humans, is a further incentive to develop virotherapeutic agents from this virus. For example, it is now well established that reovirus preferentially infects and kills cancer cells. It can be further envisaged developing the virus as a gene-transfer vector. On the contrary, new pathogenic isolates of reovirus have been reported in the last few years, suggesting the possibility of emerging reoviruses that could represent new threats to humans and animals. During the last 25 years, members of the laboratory have significantly contributed to our understanding of the virus. Molecular biology, biochemistry, and classical genetics approaches, have been especially useful to dissect the structure and function of many viral proteins. In 2007, we witnessed a major progress with the development of a new and powerful method of plasmid-based reverse genetics which could be used to produce various viral mutants, using genetic engineering. This was a major progress, now allowing to study the effect of various changes to the viral proteins in the context of the viral replicative cycle. We were among the few laboratories to readily adopt this promising approach. It has been used extensively in the last few years to produce and study new reovirus variants that possess potentially interesting properties. In the studies proposed herein, three different viral capsid proteins will be studied: these play different, yet incompletely understood, roles, especially in virus entry, synthesis of viral nucleic acids and control of the host-cell response to infection. In addition to the net gains in fundamental knowledge, our research program is motivated by longer-term objectives aimed at developing and optimizing applications of the virus as well as achieving better control of the possible emerging pathogens.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2017-03736
Name nom
Lemay, Guy
Department département
Microbiologie et immunologie - Microbiologie et immunologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
1
Nb partie
5
Application title
Molecular dissection studies of mammalian reovirus proteins using reverse genetics.
Keyword
NSERC
Application summary
Mammalian reovirus has played an important role in our understanding of important biological mechanisms: virus entry, synthesis of nucleic acids and proteins, virus evolution, and more. In addition to its interest as a fundamental research tool, possible applications are now envisaged for this fascinating virus. In fact, some viruses, such as reovirus, could become our allies rather than just enemies to fight. Its ability to infect human beings, as well as a large number of animal species, without causing disease in humans, is a further incentive to develop virotherapeutic agents from this virus. For example, it is now well established that reovirus preferentially infects and kills cancer cells. It can be further envisaged developing the virus as a gene-transfer vector. On the contrary, new pathogenic isolates of reovirus have been reported in the last few years, suggesting the possibility of emerging reoviruses that could represent new threats to humans and animals. During the last 25 years, members of the laboratory have significantly contributed to our understanding of the virus. Molecular biology, biochemistry, and classical genetics approaches, have been especially useful to dissect the structure and function of many viral proteins. In 2007, we witnessed a major progress with the development of a new and powerful method of plasmid-based reverse genetics which could be used to produce various viral mutants, using genetic engineering. This was a major progress, now allowing to study the effect of various changes to the viral proteins in the context of the viral replicative cycle. We were among the few laboratories to readily adopt this promising approach. It has been used extensively in the last few years to produce and study new reovirus variants that possess potentially interesting properties. In the studies proposed herein, three different viral capsid proteins will be studied: these play different, yet incompletely understood, roles, especially in virus entry, synthesis of viral nucleic acids and control of the host-cell response to infection. In addition to the net gains in fundamental knowledge, our research program is motivated by longer-term objectives aimed at developing and optimizing applications of the virus as well as achieving better control of the possible emerging pathogens.